|Videos|April 8, 2021
Meet the Board: Jon I. Einarsson, MD, MPH, PHD
Author(s)Jon I. Einarsson, MD, PhD, MPH
Introducing Contemporary OB/GYN®'s Deputy Editor, Jon I. Einarsson, MD, MPH, PhD.
Advertisement
Meet Contemporary OB/GYN®'s Deputy Editor, Jon I. Einarsson, MD, MPH, PhD in this segment of Meet the Board.
Advertisement
Related to this article
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, reframe testosterone candidacy around clinical presentation and hormone state, not age cutoffs or a single number on a chart.
Before prescribing testosterone, know what the evidence actually proves. Maria Uloko, MD, draws a sharp line between the one population the data supports and the much wider group of women asking about it.
Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.
David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.
SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.
Hugh Taylor, MD, welcomes ACOG's new guidance allowing clinical, nonsurgical diagnosis of endometriosis and emphasizes it is a systemic disease affecting the whole body.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
SMFM: Managing high-risk pregnancies amid abortion care restrictions
2
Pellet therapy and practical advice for hesitant prescribers
3
Reviewing the evidence about testosterone in women
4
FDA accepts extended duration sNDA for MIUDELLA IUD
5